It is the first study to examine the impact of the relationship between physicians and the pharmaceutical industry on the prescription of opioids or painkillers in the New York state.
For every extra dollar a doctor received in opioid-related payments, the doctor prescribed at least $10 or more of additional opioids. Researchers found that doctors who started to accept more payments from pharmaceutical companies ended up increasing their opioid prescription rates significantly more than those who did not.
Follow the Money
Payments from opioid manufacturers to physicians were made in the form of speaking fees, honoraria, food, and beverages. Between 2013 and 2015, about 3,400 New York state doctors received payments totaling over $3.5 million.In 2014, a group of doctors who started receiving opioid-related payments increased their prescribing rates by 37.2 percent from the previous year and another 24.7 percent between 2014 and 2015, according to the report. In comparison, a group of similar doctors who did not receive opioid-related payments increased their prescriptions by 15.6 percent in 2014 and just 1.9 percent in 2015.
Roughly 1 in 10 physicians who prescribe opioids receives a payment. Physicians who prescribe more opioids got more opioid-related payments.
Researchers found that doctors who received payments worth $20 or less wrote $34,000 worth of opioid prescriptions on average from 2013 through 2015. That amount is equivalent to about 8,000 days’ worth of opioids, based on the average opioid costs during that time period.
Doctors who received payments worth up to $50 prescribed almost $50,000 of opioids—enough for about 12,000 days’ worth of opioids.
The group of physicians that received more than $10,000 worth of opioid-related payments—the highest group—prescribed over $1,247,896 worth of opioids on average—enough for about 300,000 days’ supply of opioids.
“The research shows clearly that promotional activities from drug companies lead to increased prescribing,” said Mark Zezza, director of policy and research at NYSHealth. Zezza said the report shows a link between payments and increased prescriptions, but cannot determine if the prescribing is inappropriate.
The findings reveal potential conflicts of interest and increases concern that money influences doctors’ prescribing habits. While these payments are legal, remuneration or payments that constitute an “inducement” are illegal and prohibited by the federal Anti-Kickback Statute, under which “the exchange (or offer to exchange), of anything of value, in an effort to induce (or reward) the referral of federal health care program business” is a criminal offense.
Other key findings revealed how in the years between 2013 to 2015, a total of 25,555 opioid payments were made to doctors. The average total payment each doctor received was $1,050.
One possible solution outlined in the report called for an outright ban on all opioid-related payments to physicians.
“Consideration should be given to banning most, if not all, physician-industry promotional interactions, particularly for controlled substances such as opioids,” the report states.